Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
Pharmacogenomics
; 19(4): 321-331, 2018 03.
Article
in En
| MEDLINE
| ID: mdl-29469671
ABSTRACT
AIM:
To assess patient perceptions and utilization of pharmacogenomics (PGx) testing in an integrated community health system.METHODS:
Fifty-seven patients completed an online survey assessing their experiences with PGx testing offered through twomethods:
a designated PGx clinic or direct access in-home testing.RESULTS:
The majority of participants perceived PGx testing as helpful in their healthcare and reported understanding their results. Some had concerns about privacy and discrimination; most lacked familiarity with the Genetic Information Nondiscrimination Act. There were no significant differences in views between participants tested through either model.CONCLUSION:
Participants reported value in both methods of PGx testing. Patient experiences, understanding and result utilization will play an important role in informing future development and implementation of PGx programs.Key words
Full text:
1
Database:
MEDLINE
Main subject:
Pharmacogenetics
/
Delivery of Health Care
/
Precision Medicine
/
Pharmacogenomic Testing
Type of study:
Prognostic_studies
/
Qualitative_research
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Pharmacogenomics
Journal subject:
FARMACOLOGIA
/
GENETICA MEDICA
Year:
2018
Type:
Article
Affiliation country:
United States